Cargando…

Blood–brain barrier: mechanisms governing permeability and interaction with peripherally acting μ-opioid receptor antagonists

The blood–brain barrier (BBB) describes the unique properties of endothelial cells (ECs) that line the central nervous system (CNS) microvasculature. The BBB supports CNS homeostasis via EC-associated transport of ions, nutrients, proteins and waste products between the brain and blood. These transp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viscusi, Eugene R, Viscusi, Andrew R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Education
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476292/ https://www.ncbi.nlm.nih.gov/pubmed/32723840 http://dx.doi.org/10.1136/rapm-2020-101403

Ejemplares similares

Peripherally Acting μ-Opioid Receptor Antagonists in the Management of Postoperative Ileus: a Clinical Review
por: Chamie, Karim, et al.
Publicado: (2020)

Methylnaltrexone: Peripherally Acting µ-Opioid Receptor Antagonist
por: Uritsky, Tanya J.
Publicado: (2019)

Clinical Overview and Considerations for the Management of Opioid-induced Constipation in Patients With Chronic Noncancer Pain
por: Viscusi, Eugene R.
Publicado: (2019)

Pharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation
por: Floettmann, Eike, et al.
Publicado: (2017)

Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy
por: Pergolizzi, Joseph V, et al.
Publicado: (2017)

Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications
por: Streicher, John M., et al.
Publicado: (2017)

Pharmacologic effects of naldemedine, a peripherally acting μ‐opioid receptor antagonist, in in vitro and in vivo models of opioid‐induced constipation
por: Kanemasa, Toshiyuki, et al.
Publicado: (2019)

Efficacy and Safety of Peripherally Acting μ-Opioid Receptor Antagonist (PAMORAs) for the Management of Patients With Opioid-Induced Constipation: A Systematic Review
por: Rekatsina, Martina, et al.
Publicado: (2021)

Peripherally acting opioid receptor antagonists in pediatric patients
por: Nair, Abhijit
Publicado: (2018)

APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy
por: Viscusi, Eugene R, et al.
Publicado: (2019)

Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis
por: Viscusi, Eugene R., et al.
Publicado: (2016)

Neuraxial and peripheral misconnection events leading to wrong-route medication errors: a comprehensive literature review
por: Viscusi, Eugene R, et al.
Publicado: (2021)

In response: neuraxial and peripheral misconnection events leading to wrong-route medication errors
por: Viscusi, Eugene, et al.
Publicado: (2021)

Is Peripheral Immunity Regulated by Blood-Brain Barrier Permeability Changes?
por: Bargerstock, Erin, et al.
Publicado: (2014)

Introducing a Fresh Cadaver Model for Ultrasound-guided Central Venous Access Training in Undergraduate Medical Education
por: Miller, Ryan, et al.
Publicado: (2016)

APOLLO‐2: A Randomized, Placebo and Active‐Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein–Biased Ligand at the μ‐Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty
por: Singla, Neil K., et al.
Publicado: (2019)

Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation
por: Anantharamu, Tejus, et al.
Publicado: (2015)

The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
por: Pergolizzi Jr, Joseph V, et al.
Publicado: (2020)

Opioid-induced Constipation: A Review of Health-related Quality of Life, Patient Burden, Practical Clinical Considerations, and the Impact of Peripherally Acting μ-Opioid Receptor Antagonists
por: Argoff, Charles E.
Publicado: (2020)

Efficient Enhancement of Blood-Brain Barrier Permeability Using Acoustic Cluster Therapy (ACT)
por: Åslund, Andreas K.O., et al.
Publicado: (2017)

μ Opioid receptor: novel antagonists and structural modeling
por: Kaserer, Teresa, et al.
Publicado: (2016)

Perioperative Management of Interscalene Block in Patients with Lung Disease
por: Schwenk, Eric S., et al.
Publicado: (2013)

Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression: A randomized, double‐blind, placebo‐controlled trial
por: Viscusi, Eugene R., et al.
Publicado: (2021)

Response to the letter to the editor by Hafer and Johnson concerning ‘Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain’
por: Ottoboni, Thomas, et al.
Publicado: (2020)

Peripheral Blood and Salivary Biomarkers of Blood–Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts
por: Janigro, Damir, et al.
Publicado: (2021)

The Efficacy and Safety of the Fentanyl Iontophoretic Transdermal System (IONSYS(®)) in the Geriatric Population: Results of a Meta-Analysis of Phase III and IIIb Trials
por: Viscusi, Eugene R., et al.
Publicado: (2016)

Letter to the Editor: Ketamine for pain management: let's not neglect practical concerns
por: Cohen, Steven P., et al.
Publicado: (2019)

Blood-brain barrier permeability and physical exercise
por: Małkiewicz, Marta A., et al.
Publicado: (2019)

Fumaroylamino-4,5-epoxymorphinans and Related Opioids with Irreversible μ Opioid Receptor Antagonist Effects
por: Moynihan, Humphrey A., et al.
Publicado: (2012)

Bulletproof your job: 4 simple strategies to ride out the rough times and come out on top at work
por: Viscusi, Stephen
Publicado: (2008)

Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors
por: Puls, Kristina, et al.
Publicado: (2022)

Blood-brain barrier permeability following traumatic brain injury
por: Jungner, M, et al.
Publicado: (2012)

Crystal structure of the μ-opioid receptor bound to a morphinan antagonist
por: Manglik, Aashish, et al.
Publicado: (2012)

Blood-brain barrier permeability analysis of plant ceramides
por: Eguchi, Koichi, et al.
Publicado: (2020)

Zonulin and blood–brain barrier permeability are dissociated in humans
por: Stuart, Charlotte M., et al.
Publicado: (2022)

HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in herniorrhaphy: results from the phase 3 EPOCH 2 study
por: Viscusi, E., et al.
Publicado: (2019)

Rapid uptake of sumatriptan into the brain: An ongoing question of blood-brain barrier permeability
por: Holland, Philip R, et al.
Publicado: (2020)

Interactions of peripheral and central μ opioid systems during emotional stress
por: Bashkatova, Valentina, et al.
Publicado: (2010)

NSAIDs for analgesia in the era of COVID-19
por: Herzberg, Daniel L, et al.
Publicado: (2020)

Peripherally Acting Opioids in Orofacial Pain
por: Liu, Qing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qpg6snc3gdga01114qgrcgeacv